Eraglusib with gemcitabine and nab-paclitaxel achieved statistical significance in the first-line treatment of metastatic ...

Imfinzi plus BCG induction and maintenance therapy showed a statistically and clinically meaningful improvement in DFS for ...

Dr. Kara Kelly discusses some of the most common challenges faced by adolescent and young adult patients with lymphoma.

After cancer, lifelong infusions were tough — until nurse Angela’s care and kindness reminded me that true support can last long after treatment ends.

The first trial site has been initiated in the pivotal phase 3 OVATION 3 study which will investigate IMNN-001 for newly ...

Biomarker testing is vital for all patients with lung cancer, especially younger individuals who have higher rates of ...

Treatment with the Avmapki Fakzynja Co-pack received accelerated FDA approval for previously treated low-grade serous ovarian ...

I’m 22 years out from breast cancer and forever grateful for the nurses who gave me not just treatment but friendship, ...

Danyelza is now a recommended treatment in NCCN guidelines for relapsed or refractory high-risk neuroblastoma, a type of ...

Dr. Kara Kelly discusses the unique challenges that adolescent and young adult patients with cancer face following their ...

Treatment with an Enhertu regimen significantly improved pathologic complete responses for patients with high-risk ...

Panelists discuss how the EMERALD trial demonstrated elacestrant's efficacy in ESR1-mutated tumors, particularly in patients who had received CDK4/6 inhibitors for at least 12 months. This led to its ...